Roche says outlook is improving as revenue grows

“Previously, the company had guided for mid-to-high-single-digit growth at constant exchange rates” writes Carlo Martuscelli for The Swiss drugmaker ROG, +0.71%  said it now expects high-single-digit sales growth at constant exchange rates in 2019, with core earnings per share increasing in line with sales.

Related posts